<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01301560</url>
  </required_header>
  <id_info>
    <org_study_id>2008-05-024</org_study_id>
    <nct_id>NCT01301560</nct_id>
  </id_info>
  <brief_title>Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis</brief_title>
  <official_title>Randomized Phase III Trial of Stereotactic Radiosurgery (SRS) Versus Observation for Patients With Asymptomatic Cerebral Oligo-metastases in Non-small Cell Lung Cancer (NSCLC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The need of radiosurgery is controversial for asymptomatic oligo brain metastasis for non
      small cell lung cancer (NSCLC).

      Therefore, the investigators do a randomized study comparing overall survival between two
      groups with or without radiosurgery for asymptomatic oligo brain metastasis before palliative
      chemotherapy for NSCLC.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2008</start_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>overall survival</measure>
    <time_frame>1 year after the enrollment of the last patient</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to CNS progression</measure>
    <time_frame>1 year after the enrollment of the last patient</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">176</enrollment>
  <condition>Nonsmall Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Radiosurgery arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Radiosurgery before palliative chemotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observation arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No radiotherapy or local treatment until specific symptoms or sign developed</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiosurgery</intervention_name>
    <description>Gamma knife surgery for asymptomatic oligo-metastasis to brain from NSCLC</description>
    <arm_group_label>Radiosurgery arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>No local treatment</description>
    <arm_group_label>Observation arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Histologically confirmed non-small cell lung cancer with synchronous brain metastases

          2. One to 4 intraparenchymal brain metastases by contrast-enhanced MRI, meeting the
             following criteria:

               -  Well circumscribed tumor(s) with brain edema Grade 0-1

               -  Maximum diameter â‰¤ 3.0 cm

          3. No prior surgical treatment or RT for brain metastases

          4. No leptomeningeal metastases by MRI or cerebrospinal fluid evaluation

          5. Patients without any symptoms or signs from brain metastases (RTOG neurologic
             functions status of 0)

          6. Age, 18 and over

          7. ECOG performance status 0-1

          8. Written informed consent

        Exclusion Criteria:

          1. severe co-morbid illness and/or active infections

          2. pregnant or lactating women

          3. RTOG neurologic function status of 1~4

          4. Uncontrollable extracranial metastases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Myung-Ju Ahn, Pf</last_name>
    <phone>82-2-3410-3459</phone>
    <email>silkahn@skku.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myung-Ju Ahn, Pf</last_name>
      <phone>822-3410-3459</phone>
      <email>silkahn@skku.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2011</study_first_submitted>
  <study_first_submitted_qc>February 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2011</study_first_posted>
  <last_update_submitted>February 22, 2011</last_update_submitted>
  <last_update_submitted_qc>February 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Myung-Ju Ahn / Professor</name_title>
    <organization>Samsung Medical Center</organization>
  </responsible_party>
  <keyword>Asymptomatic brain metastasis</keyword>
  <keyword>NSCLC</keyword>
  <keyword>GKS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

